New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Body Fat Without Loss of Muscle Mass The natural GLP-1 activator is clinically shown to support fat loss, including visceral fat reduction, while preserving lean muscle AUCKLAND, New Zealand, July 23, 2026 --(BUSINESS WIRE)--Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, announces today the publication of a new clinical study in US medical journal, Obesity Pillars, demonstrating Calocurb's effectiveness in weight loss and muscle preservation
[4] Type 2 Diabetes Trials are indicating the treatment may improve blood sugar control to help manage type 2 diabetes in people with obesity
USA 110 , 52115216 (2013) Tom Burnley, B ., Afonine, P
GLP-1 medications like semaglutide and tirzepatide are game-changers in the world of medical weight lossbut how long should you actually stay on them